Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Sell
22,000
-500
-2% -$9.03K ﹤0.01% 1115
2026
Q1
$394K Hold
22,500
﹤0.01% 1205
2025
Q4
$298K Buy
22,500
+4,700
+26% +$41.7K ﹤0.01% 1337
2025
Q3
$105K Sell
17,800
-3,300
-16% -$15.5K ﹤0.01% 1823
2025
Q2
$87.1K Sell
21,100
-13,000
-38% -$52.4K ﹤0.01% 1909
2025
Q1
$128K Buy
+34,100
New +$158K ﹤0.01% 1612

Other funds holding BIOA

STRS Ohio's BIOA Position: Q2 2026 in Review

STRS Ohio reduced its BioAge Labs (BIOA) stake by 2.2% in Q2 2026, selling an estimated $9.03K and leaving 22,000 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

STRS Ohio first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • STRS Ohio held 22,000 shares of BioAge Labs worth $539K as of Q2 2026.
  • STRS Ohio sold 500 BioAge Labs shares in Q2 2026, an estimated $9.03K.
  • BioAge Labs made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1115 holding.
  • STRS Ohio first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.